Hedge Fund - Cormorant Asset Management
Eyepoint Pharmaceuticals Inc ()
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q2 (2025-06-30) | $78,338,250 | 5.84% | 8,325,000 | $ |
| 2 | 2025 - Q1 (2025-03-31) | $45,121,500 | 3.39% | 8,325,000 | $ |
| 3 | 2024 - Q4 (2024-12-31) | $62,021,250 | 3.4% | 8,325,000 | $ |
| 4 | 2024 - Q3 (2024-09-30) | $66,516,750 | 3.52% | 8,325,000 | $ |
| 5 | 2024 - Q2 (2024-06-30) | $72,427,500 | 4.18% | 8,325,000 | $ |
| 6 | 2024 - Q1 (2024-03-31) | $142,483,167 | 6.25% | 6,893,235 | $ |
| 7 | 2023 - Q4 (2023-12-31) | $139,543,611 | 6.66% | 6,038,235 | $ |
| 8 | 2023 - Q3 (2023-09-30) | $25,568,000 | 1.49% | 3,200,000 | $ |
| 9 | 2023 - Q2 (2023-06-30) | $27,840,000 | 1.55% | 3,200,000 | $ |
| 10 | 2023 - Q1 (2023-03-31) | $662 | 0.04% | 225,065 | $ |
The displayed share prices are average quarterly stock market prices.